Condition
Healthy Volunteers
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 216 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownA Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy ParticipantsNCT07656454 · 2026-06-17
RECRUITINGA Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or ObesityNCT07578584 · 2026-05-07
RECRUITINGA Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DMNCT07570992 · 2026-05-04
RECRUITINGPhase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild HypertensionNCT07803835 · 2026-03-19
RECRUITINGUltralow Dose PET Imaging of 18F-Florbetapir, 18F-FlutemetamolNCT07012993 · 2025-05-20
RECRUITINGA Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)NCT06917742 · 2025-04-09
RECRUITINGDefining Retinal Structures Using Hyperspectral Retinal ImagingNCT07555574 · 2025-01-01
RECRUITINGHyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human BodyNCT06645691 · 2024-10-17
RECRUITINGSafety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and PatientsNCT06324604 · 2024-06-13
RECRUITINGThe Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy ExpenditureNCT05545306 · 2023-06-06
RECRUITINGPreparation and Feasibility of Exams for Expected StudiesNCT05698810 · 2023-03-20
RECRUITING4D-MRI for Precision MedicineNCT04657042 · 2020-11-05
RECRUITINGNeurobiology of SuicideNCT02543983 · 2015-12-01
RECRUITINGChildren s Growth and Behavior StudyNCT02390765 · 2015-04-21
RECRUITINGNew Heart Imaging Techniques to Evaluate Possible Heart DiseaseNCT01399385 · 2011-07-06
RECRUITINGPhysical and Behavioral Traits of Overweight and Obese AdultsNCT00428987 · 2007-03-08
RECRUITINGApheresis to Obtain Plasma or White Blood Cells for Laboratory StudiesNCT00114647 · 1984-01-09
RECRUITINGSustained Release Oral Formulation For Treatment Of Parkinsons DiseaseNCT07709741 · 2027-04-01
NOT_YET_RECRUITINGWeight Gain Prevention in Adolescents and Young AdultsNCT06905626 · 2026-11-01
NOT_YET_RECRUITINGEvaluation of Safety, Side Effects, and How the Drug, Inhaled CHF10136, Is Absorbed, Modified and Removed From the Body in Healthy Adults and Adults With AsthmaNCT07851623 · 2026-10-01
NOT_YET_RECRUITINGA Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)NCT07843459 · 2026-10-01
NOT_YET_RECRUITINGPhase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With ObesityNCT07824804 · 2026-09-18
NOT_YET_RECRUITINGA Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's DiseaseNCT07787169 · 2026-09-01
NOT_YET_RECRUITINGA Study of LY4405094 in Healthy Participants and Participants With Alzheimer's DiseaseNCT07787182 · 2026-09-01
NOT_YET_RECRUITINGA Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male ParticipantsNCT07744828 · 2026-08-19
NOT_YET_RECRUITINGA Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or OverweightNCT07499050 · 2026-03-30
ACTIVE_NOT_RECRUITINGA Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass IndicesNCT07044401 · 2025-07-14
COMPLETEDSustained Release Oral Formulation for Treatment of Parkinson's DiseaseNCT05471609 · 2025-06-12
COMPLETEDInduction of Dreaming With EEG and Anesthesia in Healthy AdultsNCT07198711 · 2025-05-20
ENROLLING_BY_INVITATION"Core Stabilization Strenght and Pelvic Floor Functions in Primary Sjogren's"NCT06879444 · 2025-02-05
ENROLLING_BY_INVITATIONEvaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory DisordersNCT06661252 · 2025-01-08
COMPLETEDPET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPFNCT06683612 · 2024-12-09
COMPLETEDCritical Food Ingredients on Immunocompetence to Prevent the Risk and Development of Obesity/Metabolic SyndromeNCT07496320 · 2024-10-23
COMPLETEDA Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the SkinNCT06625307 · 2024-10-03
COMPLETEDA Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's SyndromeNCT06544642 · 2024-08-21
TERMINATEDA Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy ParticipantsNCT06360211 · 2024-04-17
COMPLETEDA Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy ParticipantsNCT06348888 · 2024-04-10
COMPLETEDAirvo 3 Respiratory Rate Validation StudyNCT06329609 · 2024-04-01
UNKNOWNA Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy ParticipantsNCT06378658 · 2024-03-29
COMPLETEDA Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy ParticipantsNCT06329895 · 2024-03-25
COMPLETEDA Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male ParticipantsNCT06221475 · 2024-01-25
COMPLETEDLeucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's DiseaseNCT06206824 · 2024-01-18
COMPLETEDA Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295NCT06144684 · 2023-11-29
COMPLETEDEffect of Administration of Itraconazole on the Pharmacokinetics of S-309309 in Healthy ParticipantsNCT06106334 · 2023-11-15
COMPLETEDSafety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsNCT05799274 · 2023-11-09
ACTIVE_NOT_RECRUITINGA Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy VolunteersNCT06103877 · 2023-11-01
COMPLETEDIntegrating ePReBMs From Phoenix in Respiratory DiseasesNCT05827302 · 2023-10-11
TERMINATEDA Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese ParticipantsNCT06139055 · 2023-10-02
UNKNOWNA Study Assessing the Safety of Oral ATH-399A in Healthy Adult ParticipantsNCT06088784 · 2023-09-19
COMPLETEDUnderstanding Balance Impairment in COPDNCT05984498 · 2023-07-17
COMPLETEDA Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male ParticipantsNCT07116512 · 2023-05-02
COMPLETEDEffect of Concurrent and Aerobic Exercise on VO2max, Strength, and Body Composition in Overweight and Obese AdultsNCT05867498 · 2023-04-17
COMPLETEDA Study to Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Japanese and Han Chinese ParticipantsNCT05686980 · 2023-01-17
COMPLETEDA Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid ArthritisNCT05638854 · 2022-12-08
COMPLETEDA Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy ParticipantsNCT05613387 · 2022-11-07
COMPLETEDELE-101 Safety & Tolerability Study in Healthy Participants and Patients With DepressionNCT05434156 · 2022-10-27
ACTIVE_NOT_RECRUITINGValidate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic DisordersNCT07646015 · 2022-10-03
COMPLETEDA Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)NCT05532358 · 2022-09-12
COMPLETEDEffects of Two Virtual HIFCT Programs in Adults With Abdominal ObesityNCT05619874 · 2022-09-05
TERMINATEDA Research Study of a New Medicine NNC0113-6856 in Healthy MalesNCT05521256 · 2022-08-26
COMPLETEDCommon interventions
PlaceboDRUG41PlaceboOTHER7BAY2927088DRUG4LersivirineDRUG4SemaglutideDRUG4[18F]FlorbetapirDRUG3Florbetaben F 18OTHER3Florbetapir F18OTHER3FostamatinibDRUG3ItraconazoleDRUG3Microdialysis Catheter InsertionPROCEDURE3Oral semaglutideDRUG3RosuvastatinDRUG3[18F]APN-1607DRUG2[18F]MNI-958DRUG2CANA/MET XR FDCDRUG2CelecoxibDRUG2Dabigatran EtexilateDRUG2DulaglutideDRUG2insulin glargineDRUG2LY2605541DRUG2LY4405094DRUG2Metformin XR, 500 mgDRUG2MidazolamDRUG2RV1729 matching placebo single doseDRUG2
Leading sponsors
Novo Nordisk A/S
19
AstraZeneca
12
Eli Lilly and Company
9
Pfizer
9
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
8
Bayer
7
Respivert Ltd
5
Hartford Hospital
4
Janssen Research & Development, LLC
4
MedImmune LLC
4
University of Minnesota
4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
3
Invicro
3
National Institute of Allergy and Infectious Diseases (NIAID)
3
National Institutes of Health Clinical Center (CC)
3
Trial status mix
COMPLETED156
RECRUITING17
TERMINATED15
UNKNOWN11
NOT_YET_RECRUITING8
ACTIVE_NOT_RECRUITING3
ENROLLING_BY_INVITATION3
WITHDRAWN3
Phase mix
PHASE1137
NA35
EARLY_PHASE18
PHASE28
PHASE43
PHASE32
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.